Revolutionizing Cancer Diagnostics

Empowering Precision Medicine through Computational Intelligence.

What We Offer

Integrated Organoid & Analytical Services

We provide full-lifecycle support for organoid research, from development and sequencing to advanced computational analysis.

Organoid Development

We generate and maintain high-fidelity tumor organoids derived from clinical or research samples. Our organoid systems preserve critical biological characteristics, making them ideal for cancer research and experimental programs.

What We Offer:

  • Establishment of primary tumor organoids
  • Expansion and routine maintenance
  • Morphological and growth evaluation
  • Cryopreservation and recovery options

Organoid Sequencing

We provide sequencing services optimized for organoid-based research. Our workflows ensure reliable molecular profiling suitable for discovery or translational applications.

Available Assays:

  • RNA sequencing
  • Whole-exome sequencing
  • Targeted oncology gene panels
  • DNA/RNA extraction and QC assessment

Organoid Analytics

We deliver structured analytical summaries derived from organoid studies, helping teams interpret experimental outcomes with clarity and biological context. All outputs maintain strict confidentiality and do not disclose proprietary internal methodologies.

Analytics May Include:

  • Gene-level summaries
  • Comparative analysis across conditions
  • Growth kinetics and behavior metrics
  • Research-oriented interpretations

Custom Research Programs

We collaborate with hospitals, oncology groups, academic laboratories, and biotech partners to execute specialized organoid-based projects tailored to specific scientific or clinical goals.

Organoid Systems we offer

Our library includes tumor organoids across several cancer types, with continuous expansion based on research and clinical requirements. Custom organoid development is available on request.

Currently Available:

  • Glioblastoma
  • Breast Cancer
  • Colon Cancer
  • Multiple Myeloma
  • Lung Cancer
  • Cervical Cancer
Partnerships that Power Progress

Our Trusted Collaborators

Working with Trusted Collaborators

Strategic cooperation partners who collaborate with us to deliver cutting-edge solutions in oncology research and diagnostics.

Together, we're building the future of cancer research and treatment approaches.

Learn about partnership opportunities
Aether Health
Basavatarakam Indo-American Cancer Hospital & Research Institute
CIHR - Canadian Institutes of Health Research
Henry Ford Health
Medisetti Cancer Institute
NSERC
Porter Lab
Share
University of Windsor
Collaboration and Partnership Illustration

Work with us

OncoBridge Bio partners with institutions across the oncology ecosystem to support:

  • Translational research
  • Experimental therapeutics
  • Diagnostic development
  • Preclinical discovery
  • Academic research programs

Our collaboration models are flexible and built around scientific quality, transparency, and timely execution.

Start a Collaboration
Who We Are

About OncoBridge Bio

OncoBridge Bio is a modern oncology solutions company focused on developing advanced tumor models and computational frameworks that enable deeper biological understanding. We support clinicians, researchers, and industry partners by providing accurate, biology-grounded systems that enhance cancer diagnostics, discovery, and translational research. Serving clients around the world.

DNA Helix and Data Overlay

Our Mission

To empower precision medicine through high-quality tumor modeling, streamlined experimental workflows, and structured biological insights.

A future where every cancer patient benefits from diagnostics developed using biologically relevant tumor systems and reliable analytical frameworks.

Lab Equipment and Data Dashboard

Our Approach

We bring together standardized laboratory workflows, robust experimental systems, and computational interpretation to deliver consistent, high-resolution biological information.

Our solutions are designed to support research programs, early discovery, and translational oncology initiatives.

Our Leadership Team

A blend of clinical, scientific, technological, and business expertise driving precision oncology forward.

Dr. Srinath Kandalam

Founder

MBBS, Clinical Research, Internal Medicine (Cert.)

Precision oncology + Clinical AI integration

Dr. Dorota Lubanska

Co-Founder

Ph.D Organoid biology specialist

Leads PDO & biobank programs

Dr. Lisa Porter

Scientific Advisor

Ph.D, Distinguished Professor

Founding Director, WE SPARK Health Institute, Distinguished Professor, Biomedical Sciences, University of Windsor

Uday Deorukhakar

Head of Technology

Technology architecture & Governance

Strategic technical leadership

Dr. Hima Tej Eppanapally

Business Development (U.S.)

Strategic Partnerships & Market Expansion

Driving international growth and commercial strategy

Akash Bhatia

Technology & Business Advisor

Co-founder & CFO, Infinite Analytics

Strategic technology and business development

Snehith Allamraju

Data and Analytics Advisor

Director, Data & Analytics at RSM US LLP

Advanced analytics and data strategy

Questions or Comments?

We know that our clients have unique needs. Send us a message, and we will get back to you soon.

OncoBridge Bio

Email: info@oncobridgebio.com